Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 22 studies | 31% ± 7% | |
CD4-positive, alpha-beta T cell | 20 studies | 24% ± 7% | |
T cell | 11 studies | 23% ± 7% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 11 studies | 19% ± 4% | |
macrophage | 9 studies | 21% ± 5% | |
mucosal invariant T cell | 8 studies | 20% ± 4% | |
CD4-positive, alpha-beta memory T cell | 7 studies | 28% ± 8% | |
T follicular helper cell | 6 studies | 27% ± 6% | |
CD8-positive, alpha-beta T cell | 5 studies | 25% ± 6% | |
effector memory CD4-positive, alpha-beta T cell | 4 studies | 31% ± 8% | |
effector CD4-positive, alpha-beta T cell | 3 studies | 32% ± 8% | |
CD4-positive helper T cell | 3 studies | 22% ± 5% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of CD28 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 351.66 | 567 / 578 | 81% | 3.31 | 940 / 1155 |
breast | 90% | 198.99 | 415 / 459 | 80% | 3.24 | 893 / 1118 |
intestine | 68% | 230.43 | 654 / 966 | 53% | 1.49 | 280 / 527 |
prostate | 58% | 74.72 | 143 / 245 | 59% | 1.74 | 298 / 502 |
stomach | 53% | 51.38 | 191 / 359 | 63% | 2.04 | 181 / 286 |
kidney | 47% | 88.28 | 42 / 89 | 69% | 2.55 | 622 / 901 |
bladder | 67% | 94.24 | 14 / 21 | 49% | 1.41 | 247 / 504 |
skin | 34% | 34.09 | 609 / 1809 | 74% | 3.67 | 350 / 472 |
thymus | 55% | 115.14 | 357 / 653 | 46% | 2.80 | 276 / 605 |
spleen | 100% | 816.59 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 425.17 | 1181 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1015.87 | 900 / 929 | 0% | 0 | 0 / 0 |
liver | 54% | 52.79 | 121 / 226 | 42% | 1.02 | 170 / 406 |
uterus | 45% | 41.39 | 77 / 170 | 50% | 1.30 | 230 / 459 |
lymph node | 0% | 0 | 0 / 0 | 93% | 18.72 | 27 / 29 |
esophagus | 34% | 36.49 | 493 / 1445 | 55% | 1.63 | 101 / 183 |
tonsil | 0% | 0 | 0 / 0 | 78% | 4.46 | 35 / 45 |
blood vessel | 75% | 228.77 | 1007 / 1335 | 0% | 0 | 0 / 0 |
ovary | 33% | 30.26 | 59 / 180 | 37% | 0.69 | 158 / 430 |
pancreas | 2% | 1.19 | 6 / 328 | 61% | 2.39 | 109 / 178 |
adrenal gland | 14% | 9.38 | 36 / 258 | 21% | 0.51 | 49 / 230 |
heart | 33% | 34.50 | 282 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 24% | 0.59 | 19 / 80 |
brain | 1% | 0.86 | 27 / 2642 | 9% | 0.21 | 60 / 705 |
muscle | 8% | 7.30 | 67 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0002863 | Biological process | positive regulation of inflammatory response to antigenic stimulus |
GO_0035739 | Biological process | CD4-positive, alpha-beta T cell proliferation |
GO_0031295 | Biological process | T cell costimulation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0045070 | Biological process | positive regulation of viral genome replication |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_0006959 | Biological process | humoral immune response |
GO_0045066 | Biological process | regulatory T cell differentiation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0048304 | Biological process | positive regulation of isotype switching to IgG isotypes |
GO_0045589 | Biological process | regulation of regulatory T cell differentiation |
GO_2000563 | Biological process | positive regulation of CD4-positive, alpha-beta T cell proliferation |
GO_0045727 | Biological process | positive regulation of translation |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0045060 | Biological process | negative thymic T cell selection |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0042110 | Biological process | T cell activation |
GO_0045840 | Biological process | positive regulation of mitotic nuclear division |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0001772 | Cellular component | immunological synapse |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0098636 | Cellular component | protein complex involved in cell adhesion |
GO_0015026 | Molecular function | coreceptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CD28 |
Protein name | T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28) |
Synonyms | |
Description | FUNCTION: Involved in T-cell activation, the induction of cell proliferation and cytokine production and promotion of T-cell survival. Enhances the production of IL4 and IL10 in T-cells in conjunction with TCR/CD3 ligation and CD40L costimulation . Isoform 3 enhances CD40L-mediated activation of NF-kappa-B and kinases MAPK8 and PAK2 in T-cells . . |
Accessions | ENST00000374481.7 [P10747-2] P10747 ENST00000458610.6 [P10747-7] ENST00000324106.9 [P10747-1] |